| scholarly article | Q13442814 |
| P50 | author | Tomi Akinyemiju | Q63542026 |
| P2860 | cites work | Cancer treatment and survivorship statistics, 2012 | Q27020961 |
| Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study | Q30415050 | ||
| The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study | Q33739428 | ||
| Estrogen receptor status in relation to risk of contralateral breast cancer-a population-based cohort study. | Q34441602 | ||
| Cost-effectiveness of contralateral prophylactic mastectomy versus routine surveillance in patients with unilateral breast cancer | Q35170200 | ||
| Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. | Q35925244 | ||
| Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status | Q36339415 | ||
| Racial disparities in posttraumatic stress after diagnosis of localized breast cancer: the BQUAL study | Q36769627 | ||
| Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer | Q37237947 | ||
| Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management | Q37608824 | ||
| Aromatase inhibitors and breast cancer prevention | Q37975542 | ||
| Unilateral breast cancer: screening of contralateral breast by using preoperative MR imaging reduces incidence of metachronous cancer | Q38074936 | ||
| Adult cancer survivors: how are they faring? | Q40376507 | ||
| Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer | Q43662789 | ||
| Are mastectomy rates really increasing in the United States? | Q43668876 | ||
| Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial. | Q45965142 | ||
| Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update | Q46838391 | ||
| Increasing rates of contralateral prophylactic mastectomy - a trend made in USA? | Q50969644 | ||
| Prognosis of metachronous contralateral breast cancer according to stage at diagnosis: the importance of early detection. | Q53000901 | ||
| The effects of radiotherapy for the treatment of contralateral breast cancer | Q59706099 | ||
| Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study | Q73580673 | ||
| Method of detection of new contralateral primary breast cancer in younger versus older women | Q81403210 | ||
| Second primary in the contralateral breast after treatment of breast cancer | Q81502266 | ||
| Second cancer following cancer of the breast in Connecticut, 1935-82 | Q93675643 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 110-113 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | Gland surgery | Q27724907 |
| P1476 | title | Risk of asynchronous contralateral breast cancer: multiple approaches for a complex issue | |
| P478 | volume | 2 |
Search more.